“98.6% accurate” sounds simple. The study behind it is more interesting than the slogan.
In October 2025, researchers published a peer-reviewed study evaluating Tempdrop's overnight axillary-temperature method for detecting ovulation and classifying fertile and non-fertile days.
The headline results were strong. But to understand whether evidence is useful, we need to ask what was compared, who was studied and what the percentage actually describes.
How the study was set up
The study analysed 194 eligible menstrual cycles from 125 participants collected between April 2023 and June 2024. Participants used Tempdrop alongside the Clearblue Connected Ovulation Test System, which was used as the LH-based reference method.
Researchers then compared the ovulation timing and fertile-window classifications generated from the axillary-temperature method with the study's reference.
The main numbers
What 98.6% does, and does not, mean
The 98.6% figure describes the proportion of study days correctly classified as fertile or non-fertile according to the study's definitions and reference method.
It does not mean:
- the temperature sensor is “98.6% accurate” against core body temperature;
- Tempdrop predicts pregnancy with 98.6% accuracy;
- the exact moment of ovulation is known with 98.6% certainty;
- every future user will personally experience the same performance.
Keeping the denominator and outcome attached to the number makes the evidence much more meaningful.
What was particularly useful about the research?
It tested the actual axillary method
Previous wearable research had looked at other body sites. This study directly evaluated an overnight upper-arm temperature method.
It used a defined reference
The comparison was against an LH-based ovulation-test system rather than against app predictions or participant recollection.
It reported more than one metric
Sensitivity, specificity, overall accuracy and ovulation-date agreement give a fuller picture than one headline percentage alone.
It published the method
Peer review makes the methods and limitations available for scrutiny rather than leaving performance claims entirely inside marketing material.
How does Tempdrop fit into the wider wearable evidence?
Tempdrop's 194-cycle study now sits inside a broader evidence base for wearable fertility tracking rather than standing on its own.
A 2026 systematic review and Bayesian network meta-analysis assessed 27 studies of wearable digital technology and menstrual-cycle or fertility-window detection. Across the wearable studies used for diagnostic comparison, the pooled fertility-window accuracy was 88%. That compared with 75% for self-recorded BBT and 72% for calendar methods. Electronic hormone-testing systems also had a pooled accuracy of 88%.
The review also found that wearable temperature methods using proximal sites such as the axilla and more distal sites such as the wrist or finger produced very similar pooled accuracy. That gives useful independent context for why overnight wearable temperature tracking has become a serious fertility-tracking method rather than simply a more convenient thermometer.
These pooled figures combine different devices, algorithms and study designs, so they are category-level evidence, not a new Tempdrop-specific score or a direct Tempdrop-versus-another-brand trial.
What are the limitations?
The reference was an LH-based urine testing system, not ultrasound confirmation of follicular rupture. The study therefore evaluates agreement with that reference rather than establishing a perfect biological timestamp for ovulation.
It was also a validation study of one device and one algorithm in 125 participants, not a direct head-to-head trial against every competing wearable. The independent 2026 review is useful here because it shows the wider wearable category performing strongly across different designs while keeping the Tempdrop-specific 98.6% figure tied to the study that actually produced it.
There is also a declared conflict worth knowing about: one author was Tempdrop's founder and CEO and another was employed by Tempdrop. The paper states that the remaining authors declared no conflicts and that the research received no external funding. A declared commercial connection does not invalidate a study, but readers should know it exists.
So what can a shopper reasonably take from it?
The study provides peer-reviewed evidence that Tempdrop's overnight axillary method can identify a strong cycle-temperature pattern and showed high agreement with the study's LH-based reference.
The independent 2026 review strengthens the wider context: wearable fertility technologies as a category achieved substantially higher pooled accuracy than self-recorded BBT and calendar methods, while performing at a similar pooled level to electronic hormone-testing systems.
That is a much stronger basis for a buying decision than vague claims that a wearable “knows your body”. It also gives us a reason to be precise: Tempdrop has device-specific validation, while the wider wearable evidence supports the overall approach.
For the measurement-site question, read why Tempdrop is worn on the upper arm.
Tempdrop Fertility, Cycle & Ovulation Tracker
If research matters to your buying decision, Tempdrop now has a peer-reviewed validation study behind its axillary-temperature approach, alongside a growing independent evidence base for wearable fertility tracking more broadly.
The study: quick answers
Was the Tempdrop study peer reviewed?
Yes. It was published in the journal Sensors in October 2025 and is indexed on PubMed.
How many cycles were analysed?
194 eligible menstrual cycles from 125 participants.
What was Tempdrop compared with?
The Clearblue Connected Ovulation Test System was used as the LH-based reference method.
Does 98.6% mean temperature accuracy?
No. It was the overall fertile/non-fertile day classification accuracy under the study's definitions.
Is there research beyond Tempdrop's own validation study?
Yes. A 2026 systematic review found pooled fertility-window detection accuracy of 88% across wearable digital technologies, compared with 75% for self-recorded BBT and 72% for calendar methods. That is broader category evidence rather than a Tempdrop-specific result.
The bottom line
Tempdrop's study reported strong performance against an LH-based reference across 194 cycles, including 98.6% overall fertile/non-fertile day classification accuracy under the study's definitions. Independent 2026 research also supports wearable fertility tracking as a credible category, with pooled accuracy outperforming self-recorded BBT and calendar approaches. Together, that gives Tempdrop a stronger evidence story than one headline percentage alone.
